Product NDC: | 0009-5091 |
Proprietary Name: | Ellence |
Non Proprietary Name: | EPIRUBICIN HYDROCHLORIDE |
Active Ingredient(s): | 2 mg/mL & nbsp; EPIRUBICIN HYDROCHLORIDE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0009-5091 |
Labeler Name: | Pharmacia and Upjohn Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050778 |
Marketing Category: | NDA |
Start Marketing Date: | 19990915 |
Package NDC: | 0009-5091-01 |
Package Description: | 25 mL in 1 VIAL, SINGLE-USE (0009-5091-01) |
NDC Code | 0009-5091-01 |
Proprietary Name | Ellence |
Package Description | 25 mL in 1 VIAL, SINGLE-USE (0009-5091-01) |
Product NDC | 0009-5091 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | EPIRUBICIN HYDROCHLORIDE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19990915 |
Marketing Category Name | NDA |
Labeler Name | Pharmacia and Upjohn Company |
Substance Name | EPIRUBICIN HYDROCHLORIDE |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |